By the late 20th century, a relatively consistent picture had emerged: that in a significant proportion of patients, the positive symptoms of schizophrenia were driven by a hyperdopaminergic state in the striatum, a dysfunction that could be treated by blocking dopamine D2 receptors. The gene discussed is DRD2; the disease is schizophrenia.